Application Note

Lentivirus Platform: Optimizing Performance For De-Risked Production

Cell & Gene Therapy Scientists GettyImages-1209892070

A de-risked, reproducible, and scalable platform for efficient GMP manufacturing of lentiviral vectors is offered as part of MilliporeSigma's comprehensive viral vector development and manufacturing services.

The VirusExpress® lentivirus platform is a leading solution for suspension-based manufacturing. Its workflow is designed to optimize and de-risk lentivirus production, meeting the needs of cell and gene therapy innovators. This comprehensive platform delivers economical value, high quality, and performance with its industry-leading titer, robust recovery, streamlined and scalable workflow, comprehensive analytics, and reduced development timelines of less than 12 months.

Continue reading to learn how this platform maximizes lentiviral vector titers through upstream optimization and enriches lentiviral vector recovery through downstream optimization.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online